Use this button to switch between dark and light mode.

Copyright © 2024 LexisNexis and/or its Licensors.

Avoiding False Claims Act Risks Relating to Federal Funding for Coronavirus (COVID-19) Relief

February 23, 2021 (1 min read)

By: Matthew D. Jenkins, Hunton Andrews Kurth LLP

This article provides an overview of compliance obligations and federal False Claims Act (FCA) risks to healthcare and life sciences companies arising out of three funding streams made available in response to the COVID-19 pandemic: (1) Medicare’s Advance Payment Program, (2) the Provider Relief Fund, and (3) the Paycheck Protection Program.

False Claims Act Fundamentals

When you advise a healthcare company that receives federal funds about its compliance obligations, a basic understanding of the FCA is essential.

The FCA imposes civil penalties on persons who knowingly or with reckless disregard: CLICK HERE TO READ THE FULL ARTICLE IF YOU ARE A PRACTICAL GUIDANCE SUBSCRIBER